Targeted drug helps leukemia patients who do not benefit from initial therapy
2012-02-27
(Press-News.org) A new study has found that patients with chronic myeloid leukemia (CML) who have not responded to interferon treatments experience long-term benefits when they switch to the targeted drug imatinib. Published early online in Cancer, a peer-reviewed journal of the American Cancer Society, the study indicates that imatinib is the treatment of choice for these patients.
Imatinib, a drug that blocks the protein made by a particular cancer-causing gene, has revolutionized the treatment and prognosis of patients with CML. Now up to 93 percent of patients who take the drug as initial therapy for CML survive at least eight years, whereas prior to imatinib, patients survived an average of only three to six years.
While imatinib is now the standard drug given after a diagnosis of CML, approximately 15,000 to 20,000 patients in the United States may have started taking imatinib after failing to respond to the previous standard drug for CML, interferon. Like patients who now take imatinib as initial therapy for their cancer, these patients seem to respond well to imatinib, at least in the short term; however, little is known about their long-term prognosis.
To investigate, Hagop Kantarjian, MD, of the University of Texas MD Anderson Cancer Center in Houston, and his colleagues analyzed 368 CML patients from their institution who started taking imatinib after failing to respond to interferon. The team estimated that 68 percent of patients survived for at least 10 years. Previous research indicates that only 20 to 30 percent of patients who do not respond to interferon therapy and have no access to imatinib survive this long.
According to the authors, these findings suggest that most patients can benefit from imatinib after unsuccessful interferon treatments, and they do not have to consider other therapeutic options.
INFORMATION: END
ELSE PRESS RELEASES FROM THIS DATE:
2012-02-27
PASADENA, Calif., (February 27, 2012) – Children and adolescents who are overweight or obese are more likely to have asthma than their healthy weight counterparts, according to a new Kaiser Permanente Southern California study published in the online edition of Obesity. The study, which included more than 681,000 children between ages 6 and 19, found that the association between asthma and body mass index varied by race and ethnicity.
The study found that the association between BMI and asthma was weaker for African Americans, a group that was previously known to have ...
2012-02-27
Millions of adults suffer from the incurable disease multiple sclerosis (MS). It is relatively certain that MS is an autoimmune disease in which the body's own defense cells attack the myelin in the brain and spinal cord. Myelin enwraps the nerve cells and is important for their function of transmitting stimuli as electrical signals. There are numerous unconfirmed hypotheses on the development of MS, one of which has now been refuted by the neuroimmunologists in their current research: The death of oligodendrocytes, as the cells that produce the myelin sheath are called, ...
2012-02-27
Mathematically, is it possible to continuously deform a rough sphere into a perfect sphere? Under what situations can we solve the differential equations?
Professor Xu Xingwang of the Department of Mathematics at National University of Singapore (NUS), along with Dr Chen Xuezhang from Nanjing University of China, has established a new method to tackle this long-standing problem.
What it used to be
Of the various different ways to measure the roughness of the sphere, the scalar curvature measurement has proven to be the weakest one, resulting in a problem commonly known ...
2012-02-27
Web applications such as Google Mail, Facebook and Amazon are used every day. However, so far there are no methods to test them systematically and at low cost for malfunctions and security vulnerabilities. Therefore, computer scientists from Saarland University are working on automatic methods of testing, which check complex web applications autonomously. For the first time, they will present this work at exhibition booth F34 in hall 26 at the computer fair Cebit. The trade show will take place from March 6 to 10 in Hannover.
"Ineffective and inefficient" is Valentin ...
2012-02-27
People like to keep a safe distance from explosive substances, but in order to analyze them, close contact is usually inevitable. At the Vienna University of Technology, a new method has now been developed to detect chemicals inside a container over a distance of more than a hundred meters. Laser light is scattered in a very specific way by different substances. Using this light, the contents of a nontransparent container can be analyzed without opening it.
Scattered Light as a "Chemical Fingerprint"
"The method we are using is Raman-spectroscopy", says Professor Bernhard ...
2012-02-27
This study is part of broader research that these scientists are carrying out on the imbalance of the sexes in China and its potential consequences. This phenomenon started to be noticed during the nineteen eighties and can currently be seen in the birth rate of approximately 120 boys for every 100 girls born in the People's Republic of China. The objective of this research is precisely to analyze the effects that this disproportion can have on this society and to attempt to prevent the possible negative results it may produce.
The researchers estimate that approximately ...
2012-02-27
New research has shown that visual alerting methods are still considered to be the most trustworthy, as compared to auditory or tactile alerts. This is shown by research conducted by a team of scientists at Old Dominion University in Norfolk, VA, USA.
The research Alert Characteristics and Identification of Avatars on a Virtual Battlefield by James P. Bliss, Rachel Liebman and J. Christopher Brill is published in the current issue (6:2) of the journal Intelligent Decision Technologies.
Most research to date has been limited to the visual or auditory signal modality. ...
2012-02-27
Why is it that Mycobacterium tuberculosis can cause tuberculosis with as little as 10 cells, whereas Vibrio cholerae requires the host to ingest up to tens of millions of cells to cause cholera? This is the question that two research teams, from the Pasteur Institute, in France, and the Instituto Gulbenkian de Ciencia and the University of Lisbon, in Portugal, answer in the latest issue of the journal PLoS Pathogens. The researchers show that bacteria that are able to invade and/or destroy cells of the host's immune system have higher infectivity, whereas those that are ...
2012-02-27
Washington D.C., February 27, 2012 – In a study published in the March 2012 issue of the Journal of the American Academy of Child and Adolescent Psychiatry, Katherine Rice and colleagues, from the Marcus Autism Center, Children's Healthcare of Atlanta, and Emory University School of Medicine, used eye-tracking technology to measure the relationship between cognitive and social disability in children with autism spectrum disorders (ASD) and the ability of children with ASD to pay attention to social interactions.
The study is the largest to date to observe children with ...
2012-02-27
A collaboration between scientists in Trinity College Dublin and the United Kingdom has identified new processes that lead to the development of a novel cell implicated in allergies. The discovery has the potential for new strategies to treat asthma and other allergic diseases.
The research findings have just been published in the leading international journal Nature Immunology.
The work was performed by Professor Padraic Fallon, Science Foundation Ireland Stokes Professor of Translational Immunology of TCD's School of Medicine and Dr Andrew McKenzie of the Medical ...
LAST 30 PRESS RELEASES:
[Press-News.org] Targeted drug helps leukemia patients who do not benefit from initial therapy
